CVE:LXG LexaGene (LXG) Stock Price, News & Analysis → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free LXG Stock Alerts C$0.10 -0.03 (-19.23%) (As of 02/21/2023) Add Compare Share Share Today's RangeC$0.10▼C$0.1450-Day RangeC$0.11▼C$0.1152-Week RangeC$0.07▼C$0.31Volume2.14 million shsAverage Volume170,061 shsMarket CapitalizationC$14.77 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get LexaGene alerts: Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About LexaGene Stock (CVE:LXG)LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The company was incorporated in 2007 and is headquartered in Beverly, Massachusetts.Read More LXG Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LXG Stock News HeadlinesApril 9, 2024 | lse.co.ukPamapol Ord Share Price (0LXG)November 12, 2023 | morningstar.comBiosynex SA ALBIOApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.October 31, 2023 | morningstar.comCyclopharm Ltd CYCOctober 16, 2023 | investing.comLexagene Holdings Inc (LXGh)September 2, 2023 | morningstar.comEurobio Scientific Bearer and/or Registered shares issued from reverse spliJuly 28, 2023 | morningstar.comZhejiang Gongdong Medical Technology Co Ltd Class AFebruary 22, 2023 | finance.yahoo.comIIROC Trading Halt - LXGApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.October 20, 2022 | marketscreener.comLexaGene Says Large Biopharma Co Engages It in Statement of Work to Expedite Technology Validation - Marketscreener.comOctober 20, 2022 | globenewswire.comLarge Biopharma Company Engages LexaGene in Statement of Work to Expedite Technology Validation - GlobeNewswireOctober 19, 2022 | streetinsider.comForm 10-Q LexaGene Holdings Inc. For: Aug 31 - StreetInsider.comOctober 13, 2022 | marketscreener.comLexaGene Rises 23% as Says Got Signed Quote from Large Biopharma Company to Buy a MiQLab System - Marketscreener.comOctober 13, 2022 | marketscreener.comLexaGene Says Received Signed Quote from Large Biopharma Company to Buy a MiQLab System - Marketscreener.comOctober 13, 2022 | globenewswire.comLexaGene Receives Signed Quote from Large Biopharma Company to Purchase a MiQLab System - GlobeNewswireOctober 4, 2022 | businesswire.comVeterinary Infectious Disease Diagnostics Global Market Report 2022: Increasing Incidence of Transboundary and Zoonotic Diseases Drives Growth - ResearchAndMarkets.com - Business WireSeptember 1, 2022 | financialpost.comLexaGene Announces MiQLab® System Sale to Veterinary Hospital in California - Financial PostSeptember 1, 2022 | gurufocus.comLexaGene Announces MiQLab® Sys - GuruFocus.comSeptember 1, 2022 | benzinga.comLEXAGENE HLDGS INC ORD by Lexagene Hldgs Inc. (LXXGF), (TSXV:LXG) – LexaGene Announces MiQLab® System Sal - BenzingaAugust 29, 2022 | globenewswire.comLexaGene Verifies CDC Monkeypox Assay Works on MiQLab System and Readies Company Should an EUA be Declared - GlobeNewswireAugust 24, 2022 | globenewswire.comLexaGene's MiQLab System Generates Leptospira Results in as - GlobeNewswireAugust 23, 2022 | marketscreener.comLexaGene : OTCQB Cert - Marketscreener.comAugust 17, 2022 | marketscreener.comLexaGene Says U of Penn's School of Veterinary Medicine to Evaluate New Gastrointestinal Panel With MiQLab System - Marketscreener.comAugust 17, 2022 | globenewswire.comUniversity of Pennsylvania's School of Veterinary Medicine - GlobeNewswireAugust 10, 2022 | globenewswire.comLexaGene Reduces Time-to-Result by ~35% - GlobeNewswireAugust 9, 2022 | streetinsider.comForm 10-12G/A LexaGene Holdings Inc. - StreetInsider.comAugust 3, 2022 | finance.yahoo.comRising Transboundary And Zoonotic Disease Cases Are Fueling The Growth Of The Veterinary Infectious Disease Diagnostics Market As Per The Business Research Company's Veterinary Infectious Disease Diagnostics Global Market Report 2022 - Yahoo FinanceSee More Headlines Receive LXG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LexaGene and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolCVE:LXG CUSIPN/A CIKN/A Webwww.lexagene.com Phone800-215-1824FaxN/AEmployees41Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-8,540,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-339.54% Return on Assets-120.21% Debt Debt-to-Equity Ratio138.01 Current Ratio1.39 Quick Ratio1.13 Sales & Book Value Annual SalesC$110,927.00 Price / Sales133.13 Cash FlowC$0.00 per share Price / Cash Flow21.25 Book ValueC$0.01 per share Price / Book10.50Miscellaneous Outstanding Shares140,640,000Free FloatN/AMarket CapC$14.77 million OptionableNot Optionable Beta2.26 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesDr. John F. Regan (Age 50)Founder, Chairman & CEO Comp: $371.68kMr. Jeffrey Mitchell (Age 51)CFO, Treasurer & Corp. Sec. Comp: $293.4kMr. Steven Armstrong (Age 57)Chief Operating Officer Comp: $234.32kMr. Allan John Fabbro (Age 65)VP of Corp. Devel. Nicole RidgedaleDirector of Corp. MarketingMr. Jay AdelaarVP of Capital MarketsMore ExecutivesKey CompetitorsLED Medical DiagnosticsCVE:LMDSQI DiagnosticsCVE:SQDGeneNewsTSE:GENAkuminTSE:AKUNuvo PharmaceuticalsTSE:MRVView All Competitors LXG Stock Analysis - Frequently Asked Questions How have LXG shares performed in 2024? LexaGene's stock was trading at C$0.11 on January 1st, 2024. Since then, LXG shares have increased by 0.0% and is now trading at C$0.11. View the best growth stocks for 2024 here. What other stocks do shareholders of LexaGene own? Based on aggregate information from My MarketBeat watchlists, some companies that other LexaGene investors own include Jaguar Mining (JAG), Northern Superior Resources (SUP), Vaccinex (VCNX), Gevo (GEVO), HIVE Digital Technologies (HIVE), EQT (EQT), Freehold Royalties (FRU), GFG Resources (GFG) and IAMGOLD (IMG). How do I buy shares of LexaGene? Shares of LXG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:LXG) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LexaGene Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
